Research
Hormonal
GLP-1 receptor agonists (GLP-1 RA) are a safe and effective treatment for weight regain and insufficient weight loss after metabolic bariatric surgery.
Practitioners can consider GLP-1 RA as a viable option for patients struggling with weight management post-surgery.
StrongSupportsmedium confidence
Using GLP‐1 RA is a safe and effective treatment for weight regain and insufficient weight loss after MBS.
Why this rating
Based on a systematic review and meta-analysis.
Source
Safety and efficacy of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta‐analysis
Ali Esparham et al. · Obesity Reviews · 2024
DOI 10.1111/obr.13811
Meta-analysisCited 26×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →